Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 75 articles:
HTML format



Single Articles


    November 2022
  1. HSU YC, Chen CH, Huang HF, Lee YT, et al
    Therapeutic Effects of Anti-PD1 Immunotherapy on Hepatocellular Carcinoma Under Administration of Tacrolimus.
    Transplantation. 2022 Nov 16. pii: 00007890-990000000-00249.
    PubMed     Abstract available


    October 2022
  2. ZOU Z, Shang R, Zhou L, Du D, et al
    The Novel MyD88 Inhibitor TJ-M2010-5 Protects Against Hepatic Ischemia-reperfusion Injury by Suppressing Pyroptosis in Mice.
    Transplantation. 2022 Oct 12. pii: 00007890-990000000-00172.
    PubMed     Abstract available


    September 2022
  3. THULUVATH AJ, Siddiqui O, Lai JC, Peipert J, et al
    Personality Traits in Patients With Cirrhosis Are Different From Those of the General Population and Impact Likelihood of Liver Transplantation.
    Transplantation. 2022 Sep 29. pii: 00007890-990000000-00176.
    PubMed     Abstract available


  4. DODGE JL, Lee BT, Kassem ACZ, Biggins SW, et al
    The Conundrum of Patients With Compensated Cirrhosis Requiring Kidney Transplantation; Kidney Alone or Simultaneous Liver Kidney Transplantation.
    Transplantation. 2022 Sep 26. pii: 00007890-990000000-00171.
    PubMed     Abstract available


    August 2022
  5. SEHJAL J, Sharples LD, Keogh RH, Walker K, et al
    Time-varying Comparison of All-cause Mortality After Liver Transplantation Between Recipients With and Without Hepatocellular Carcinoma: A Population-based Cohort Study Using the United Kingdom Liver Transplant Registry.
    Transplantation. 2022 Aug 26. pii: 00007890-990000000-00149.
    PubMed     Abstract available


  6. TOVOLI F, Pallotta DP, Sansone V, Iavarone M, et al
    Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments.
    Transplantation. 2022 Aug 2. pii: 00007890-990000000-00123.
    PubMed     Abstract available


  7. HERBST LR, Herrick-Reynolds K, Bowles Zeiser L, Lopez JI, et al
    The Landscape of Nondirected Living Liver Donation in the United States.
    Transplantation. 2022;106:1600-1608.
    PubMed     Abstract available


    July 2022
  8. ZHOU S, Rao Z, Xia Y, Wang Q, et al
    CCAAT/Enhancer-binding Protein Homologous Protein Promotes ROS-mediated Liver Ischemia and Reperfusion Injury by Inhibiting Mitophagy in Hepatocytes.
    Transplantation. 2022 Jul 13. pii: 00007890-990000000-00102.
    PubMed     Abstract available


  9. PERKONS NR, Metz DC, Siegelman ES, Yang Z, et al
    Where LI-RADS Falls Short: Two Cases of Image-diagnosed HCC, Found to Be NET on Explant.
    Transplantation. 2022;106:e350-e351.
    PubMed    


    June 2022
  10. JAMIL OK, Sandikci B, Faust N, Cotter TG, et al
    Relatively Poor Long-term Outcomes Following Liver Transplantation for NASH in the United States.
    Transplantation. 2022 Jun 29. pii: 00007890-990000000-00093.
    PubMed     Abstract available


  11. DAVE S, Yang K, Schnickel GT, Kono Y, et al
    The Impact of Treatment of Hepatocellular Carcinoma With Immune Checkpoint Inhibitors on Pre- and Post-liver Transplant Outcomes.
    Transplantation. 2022;106:e308-e309.
    PubMed    


  12. PHILIP G, Hookey L, Richardson H, Flemming JA, et al
    Alcohol-associated Liver Disease Is Now the Most Common Indication for Liver Transplant Waitlisting Among Young American Adults.
    Transplantation. 2022 Jun 1. pii: 00007890-990000000-00064.
    PubMed     Abstract available


    May 2022
  13. TEJEDOR M, Selzner N, Berenguer M
    Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?
    Transplantation. 2022 May 16. pii: 00007890-990000000-00049.
    PubMed     Abstract available


  14. WANG Z, Liu D, Yan Q, Liu F, et al
    Activated AXL Protects Against Hepatic Ischemia-reperfusion Injury by Upregulating SOCS-1 Expression.
    Transplantation. 2022 May 11. pii: 00007890-990000000-00043.
    PubMed     Abstract available


  15. CANNON RM, Nassel A, Walker JT, Sheikh SS, et al
    County-level Differences in Liver-related Mortality, Waitlisting, and Liver Transplantation in the United States.
    Transplantation. 2022 May 9. pii: 00007890-990000000-00041.
    PubMed     Abstract available


    April 2022
  16. YAMANA H, Inagaki A, Imura T, Nakamura Y, et al
    Cotransplantation With Adipose Tissue-Derived Stem Cells Improves Engraftment of Transplanted Hepatocytes.
    Transplantation. 2022 Apr 11. pii: 00007890-990000000-00020.
    PubMed     Abstract available


    March 2022
  17. TROTTER J
    Commentary on Rising Trend in Waitlisting for Alcoholic Hepatitis With More Favorable Outcomes Than Other High Model for End-stage Liver Disease in the Current Era.
    Transplantation. 2022 Mar 24. pii: 00007890-900000000-95040.
    PubMed    


  18. BERRY K, Copeland T, Ku E, Lai JC, et al
    Perioperative Delta Sodium and Post-Liver Transplant Neurological Complications in Liver Transplant Recipients.
    Transplantation. 2022 Mar 14. pii: 00007890-900000000-95051.
    PubMed     Abstract available


  19. KAYAALP C
    Peritoneum for Middle Hepatic Vein Conduit During Living Donor Liver Transplantation.
    Transplantation. 2022;106:e194.
    PubMed    


  20. CHOLONGITAS E
    What Is the Impact of Mammalian Target of Rapamycin Inhibitors on Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2022;106:e189.
    PubMed    


    February 2022
  21. LIN SH, Lin MT, Wang CC, Chen CL, et al
    Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure.
    Transplantation. 2022;106:e163-e164.
    PubMed    


  22. ASHKENAZI T, Stoler A, Mor E
    The Effect of Priority Given to Donor Card Holders on the Allocation of Livers for Transplant-Evidence From 7 Years of the Israeli Priority Program.
    Transplantation. 2022;106:299-307.
    PubMed     Abstract available


    January 2022
  23. LAMM V, Ekser B, Vagefi PA, Cooper DKC, et al
    Bridging to Allotransplantation-Is Pig Liver Xenotransplantation the Best Option?
    Transplantation. 2022;106:26-36.
    PubMed     Abstract available


  24. ROTELLAR F, Ciria R, Wakabayashi G, Suh KS, et al
    World Survey on Minimally Invasive Donor Hepatectomy: A Global Snapshot of Current Practices in 2370 Cases.
    Transplantation. 2022;106:96-105.
    PubMed     Abstract available


  25. SALCEDO M, Vinaixa C, Javle M, Trapero-Marugan M, et al
    Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference.
    Transplantation. 2022;106:e3-e11.
    PubMed     Abstract available


    December 2021
  26. MOHKAM K, Abdallah R, N'kontchou G, Ganne N, et al
    Influence of the ABO Blood Group System on Hepatocellular Carcinoma Recurrence After Liver Transplantation.
    Transplantation. 2021 Dec 27. pii: 00007890-900000000-95109.
    PubMed     Abstract available


  27. WANG H
    P.150: Alpha-1 Antitrypsin Engineered Mesenchymal Stromal Cells Improves Human Islet Survival via Regulation of Macrophage Activation.
    Transplantation. 2021;105.
    PubMed    


  28. JARASVARAPARN C, Rusch C, Stoll J, Kulkarni S, et al
    Pediatric Subjects With Cirrhosis Are Not at a Higher Risk of Bleeding or Clotting due to a Rebalanced Hemostatic System.
    Transplantation. 2021;105.
    PubMed    


  29. LEE EJ, Sood V, Raghu V, Squires J, et al
    Liver Transplantation From a Heterozygous Living-related Donor Into an Alpha-1 Antitrypsin Deficient Pediatric Recipient.
    Transplantation. 2021;105.
    PubMed    


  30. BLACK K, Ziogas IA, Thurm C, Hall M, et al
    Pediatric Liver Transplant Outcomes in Alagille Syndrome: A Linked Database Analysis.
    Transplantation. 2021;105.
    PubMed    


  31. ANTALA S, Godown J, Neighbors K, Thurm C, et al
    Multi-center Study of Peri-transplant Outcomes for Acute Liver Failure in Neonates Compared to Older Infants.
    Transplantation. 2021;105.
    PubMed    


    November 2021
  32. IVANICS T, Wallace D, Abreu P, Claasen MP, et al
    Survival After Liver Transplantation: An International Comparison Between the United States and the United Kingdom in the Years 2008-2016.
    Transplantation. 2021 Nov 9. pii: 00007890-900000000-95135.
    PubMed     Abstract available


  33. XU M, Zhou F, Ahmed O, Upadhya GA, et al
    A Novel Multidrug Combination Mitigates Rat Liver Steatosis Through Activating AMPK Pathway During Normothermic Machine Perfusion.
    Transplantation. 2021;105:e215-e225.
    PubMed     Abstract available


  34. ZUCKERMAN J, Gorgen A, Acuna SA, Abreu P, et al
    Outcomes of Highly Selected Live Donors With a Future Liver Remnant Less Than or Equal to 30%: A Matched Cohort Study.
    Transplantation. 2021;105:2397-2403.
    PubMed     Abstract available


    October 2021
  35. JAMAL M, AlMahmeed H, AlGhanem M, AlMatooq M, et al
    Organ Transplantation in Kuwait and the Recent Initiation of a Liver Program.
    Transplantation. 2021;105:2125-2127.
    PubMed    


  36. YOELI D, Choudhury RA, Nydam TL, Pomposelli JJ, et al
    The Surge in Deceased Liver Donors Due to the Opioid Epidemic: Is It Time to Split the Difference?
    Transplantation. 2021;105:2239-2244.
    PubMed     Abstract available


    September 2021
  37. LIU Y, Lei Z, Chai H, Xiang S, et al
    Thrombomodulin-mediated Inhibition of Neutrophil Extracellular Trap Formation Alleviates Hepatic Ischemia/Reperfusion Injury by Blocking TLR4 in Rats Subjected to Liver Transplantation.
    Transplantation. 2021 Sep 16. pii: 00007890-900000000-95154.
    PubMed     Abstract available


  38. SCHLEGEL A, Foley DP, Savier E, Flores Carvalho M, et al
    Recommendations for Donor and Recipient Selection and Risk Prediction: Working Group Report From the ILTS Consensus Conference in DCD Liver Transplantation.
    Transplantation. 2021;105:1892-1903.
    PubMed     Abstract available


    August 2021
  39. CROOME KP, Mathur AK, Aqel B, Yang L, et al
    Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-term Outcomes From a Multicenter Cohort.
    Transplantation. 2021 Aug 30. pii: 00007890-900000000-95163.
    PubMed     Abstract available


    July 2021
  40. SOGBE M, Lopez-Guerra D, Blanco-Fernandez G, Sangro B, et al
    Durvalumab as a Successful Downstaging Therapy for Liver Transplantation in Hepatocellular Carcinoma: the Importance of a Wash-Out Period.
    Transplantation. 2021 Jul 19. pii: 00007890-900000000-95194.
    PubMed    


  41. PATRONO D, Zanierato M, Avolio AW, Romagnoli R, et al
    Different Timing of Cholangiocyte and Hepatocyte Damage in Liver Preservation: Time to Implement Donor Interventions and New Preservation Techniques to Prevent Ischemic-type Biliary Lesions.
    Transplantation. 2021;105:e77-e78.
    PubMed    


  42. MRZLJAK A, Mikulic D, Busic M, Vukovic J, et al
    Liver Transplantation in Croatia: "David Among Goliaths".
    Transplantation. 2021;105:1389-1391.
    PubMed    


  43. B N, J H, G L, A K, et al
    O-14: Portal Hypertensive Complications after Pediatric Combined Liver-intestine Transplantation from Late Vascular Compromise of Native Portacaval Shunt: Clinical Presentation and Management.
    Transplantation. 2021;105.
    PubMed    


    June 2021
  44. CENTONZE L, Lauterio A, De Carlis R, Ferla F, et al
    Successful Liver Transplantation From a Donation After Brain Death Donor With Cerebral Venous Sinus and Hepatic Veins Thrombosis Occurred After ChAdOx1 nCov-19 Vaccination.
    Transplantation. 2021 Jun 23. pii: 00007890-900000000-95222.
    PubMed    


  45. DEWITTE A, Defaye M, Dahmi A, Ouattara A, et al
    Prognostic impact of early recovering acute kidney injury following liver transplantation: a multicenter retrospective study.
    Transplantation. 2021 Jun 23. pii: 00007890-900000000-95219.
    PubMed     Abstract available


  46. LIU XB, Liu H, Liu J, Cheung AKL, et al
    Cytomegalovirus Latency Exacerbated small-for-size Liver Graft Injury through Activation of CCL19/CCR7 in Hepatic Stellate Cells.
    Transplantation. 2021 Jun 2. doi: 10.1097/TP.0000000000003846.
    PubMed     Abstract available


  47. GORGEN A, Sapisochin G
    Re: Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.
    Transplantation. 2021;105:e64.
    PubMed    


  48. SERENARI M, Ravaioli M, Cescon M
    Hepatobiliary Scintigraphy to Increase the Safety in Right Lobe Living Donor Liver Transplantation: Not Just a Matter of Age and Remnant Volume.
    Transplantation. 2021;105:e63.
    PubMed    


  49. PERI AM, Magro B, van den Bogaart L, Dalla Pria A, et al
    Successful Treatment of Suspected Donor-derived Human Herpesvirus-8 Infection in a Liver Transplant Patient With Coronavirus Disease-19.
    Transplantation. 2021;105:e65-e67.
    PubMed    


  50. CANNON RM, Goldberg DS, Eckhoff DE, Anderson DJ, et al
    Early Outcomes With the Liver-kidney Safety Net.
    Transplantation. 2021;105:1261-1272.
    PubMed     Abstract available


    April 2021
  51. SPOSITO C, Rossi RE, Monteleone M, Coppa J, et al
    Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors.
    Transplantation. 2021 Apr 27. pii: 00007890-900000000-95264.
    PubMed     Abstract available


  52. BUSCEMI V, De Carlis R, Lauterio A, Camozzi ML, et al
    Liver Transplantation From a Donor With Noonan Syndrome: Caveat Emptor.
    Transplantation. 2021;105:e50-e51.
    PubMed    


  53. BONIFAZI F, Sica S, Angeletti A, Marktel S, et al
    Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group.
    Transplantation. 2021;105:686-694.
    PubMed     Abstract available


    March 2021
  54. ELGHARABLY H, Ayyat KS, Okamoto T, Thuita L, et al
    Evolution of Recipient Characteristics Over 3 Decades and Impact on Survival After Lung Transplantation.
    Transplantation. 2021 Mar 18. doi: 10.1097/TP.0000000000003756.
    PubMed     Abstract available


  55. CAMPOS-VARELA I, Gomez-Gavara C, Augustin S
    Recommendations and guidance on nutritional supplementation in the liver transplant setting.
    Transplantation. 2021 Mar 8. pii: 00007890-900000000-95312.
    PubMed     Abstract available


  56. WEISS E, Giabicani M, Saner F
    Do Liver Transplantation Criteria Differ According to the Type of Donor and the Severity of the Recipient?
    Transplantation. 2021;105:e32.
    PubMed    


  57. XUE Y, Liu H, Yang XX, Pang L, et al
    Inhibition of Carnitine Palmitoyltransferase 1A Aggravates Fatty Liver Graft Injury via Promoting Mitochondrial Permeability Transition.
    Transplantation. 2021;105:550-560.
    PubMed     Abstract available


    February 2021
  58. DUARTE-ROJO A, Heimbach JK, Borja-Cacho D, Barone GW, et al
    Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation.
    Transplantation. 2021 Feb 23. pii: 00007890-900000000-95324.
    PubMed     Abstract available


  59. HAN S, Cho J, Wi W, Lee KW, et al
    Sex difference in the tolerance of hepatic ischemia-reperfusion injury and hepatic estrogen receptor expression according to age and macrosteatosis in healthy living liver donors.
    Transplantation. 2021 Feb 22. doi: 10.1097/TP.0000000000003705.
    PubMed     Abstract available


  60. SHAKED O, Demetris J, Levitsky J, Feng S, et al
    Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation.
    Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003681.
    PubMed     Abstract available


    January 2021
  61. IVANICS T, Salinas-Miranda E, Abreu P, Khalvati F, et al
    A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation. A Pilot Study on a Novel Biomarker.
    Transplantation. 2021 Jan 7. doi: 10.1097/TP.0000000000003605.
    PubMed     Abstract available


  62. KING EA, Brennan DC
    The Science Is Only as Good as the Data: The Case of Fontan-associated Liver Disease.
    Transplantation. 2021;105:23-24.
    PubMed    


  63. KIM MH, Nguyen A, Lo M, Kumar SR, et al
    Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
    Transplantation. 2021;105:18-22.
    PubMed     Abstract available


    November 2020
  64. KARVELLAS CJ, Francoz C, Weiss E
    Liver Transplantation in Acute-on-Chronic Liver Failure.
    Transplantation. 2020 Nov 17. doi: 10.1097/TP.0000000000003550.
    PubMed     Abstract available


    October 2020
  65. CARTIN-CEBA R, Burger C, Swanson K, Vargas H, et al
    Clinical Outcomes after Liver Transplantation in Patients with Portopulmonary Hypertension.
    Transplantation. 2020 Oct 12. doi: 10.1097/TP.0000000000003490.
    PubMed     Abstract available


  66. WALLACE D, Cowling TE, Walker K, Suddle A, et al
    The Impact of Performance Status on Length of Hospital Stay and Clinical Complications Following Liver Transplantation.
    Transplantation. 2020 Oct 8. doi: 10.1097/TP.0000000000003484.
    PubMed     Abstract available


    July 2020
  67. KAUR N, Emamaullee J, Lian T, Lo M, et al
    Impact of Morbid Obesity on Liver Transplant Candidacy and Outcomes: National and Regional Trends.
    Transplantation. 2020 Jul 31. pii: 00007890-900000000-95575.
    PubMed     Abstract available


  68. LEE SG, Jeng LB, Saliba F, Singh Soin A, et al
    Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of Two Randomized Controlled Trials.
    Transplantation. 2020 Jul 22. pii: 00007890-900000000-95581.
    PubMed     Abstract available


  69. ABU RMILAH A, Fencl R, Watt K, Krowka M, et al
    Association of alpha 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation.
    Transplantation. 2020 Jul 6. doi: 10.1097/TP.0000000000003390.
    PubMed     Abstract available


    June 2020
  70. MENAHEM B, Dejardin O, Alves A, Launay L, et al
    Socioeconomic Deprivation Does Not Impact Liver Transplantation Outcome for HCC: A Survival Analysis From a National Database.
    Transplantation. 2020 Jun 9. doi: 10.1097/TP.0000000000003340.
    PubMed     Abstract available


    May 2020
  71. BRAUN HJ, Dodge JL, Grab JD, Schwab ME, et al
    Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization.
    Transplantation. 2020 May 18. doi: 10.1097/TP.0000000000003318.
    PubMed     Abstract available


  72. KOSHY AN, Farouque O, Cailes B, Ko J, et al
    Prediction of Perioperative Cardiovascular Events in Liver Transplantation.
    Transplantation. 2020 May 11. doi: 10.1097/TP.0000000000003306.
    PubMed     Abstract available


    April 2020
  73. RODRIGUEZ-PERALVAREZ M, Gomez-Bravo MA, Sanchez-Antolin G, De la Rosa G, et al
    Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation.
    Transplantation. 2020 Apr 27. doi: 10.1097/TP.0000000000003281.
    PubMed     Abstract available


  74. AMIN A, Molina A, Quach L, Ito T, et al
    Liver Transplantation in Patients with Pretransplant Aspergillus Colonization: Is It Safe To Proceed?
    Transplantation. 2020 Apr 13. doi: 10.1097/TP.0000000000003276.
    PubMed     Abstract available


    February 2020
  75. CRON DC, Tincopa MA, Lee JS, Waljee AK, et al
    Prevalence and patterns of opioid use before and after liver transplantation.
    Transplantation. 2020 Feb 4. doi: 10.1097/TP.0000000000003155.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: